Myopathies associated with red yeast rice and liquorice: Spontaneous reports from the Italian Surveillance System of Natural Health Products

British Journal of Clinical Pharmacology

Volumn 66, Issue 4, 2008, Pages 572-574

  Lapi, Francesco ^a,b   Gallo, Eugenia ^a   Bernasconi, Sara ^a   Vietri, Michele ^a   Menniti Ippolito, Francesca ^c   Raschetti, Roberto ^c   Gori, Luigi ^d   Firenzuoli, Fabio ^d   Mugelli, Alessandro ^a   Vannacci, Alfredo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Regional Agency for Healthcare Services of Tuscany   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARMOLIPID PLUS; CHOLESTIN; COLESTAT; GLYCYRRHIZA EXTRACT; HERBADULX REGOLA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLYCYRRHIZA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; LETTER; MYALGIA; MYOPATHY; PRIORITY JOURNAL; RHABDOMYOLYSIS; SIDE EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; BIOLOGICAL PRODUCTS; FEMALE; GLYCYRRHIZA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUSCULAR DISEASES; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 51649129134     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03224.x     Document Type: Letter

References (10)

1. Tuccori M, Lombardo G, Lapi F, Vannacci A, Del Tacca M. Gabapentin-induced severe myopathy. Ann Pharmacother 2007 41: 1301 5.
2. Prasad GV, Wong T, Meliton G, Bhaloo S. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 2002 74: 1200 1.
3. Firenzuoli F, Gori L. Rhabdomyolysis due to liquorice ingestion Recenti Prog Med 2002 93: 482 3.
4. Menniti-Ippolito F, Mazzanti G, Firenzuoli F, Bianchi A, Raschetti R. Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements Ann Ist Super Sanita 2005 41: 39 42.
5. Menniti-Ippolito F, Mazzanti G, Santuccio C, Angela Moro P, Calapai G, Firenzuoli F, Valeri A, Raschetti R. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf 2008 17: 626 35 (in press).
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30: 239 45.
7. Heber D, Yip I, Ashley JM, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999 69: 231 6.
8. Capasso F. Are the herbal medicines safe? In: Phytotherapy - a Quick Reference to Herbal Medicine, Milan: Springer, 2003 13 20.
9. Yasue H, Itoh T, Mizuno Y, Harada E. Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice. Intern Med 2007 46: 575 8.
10. Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002 58: 61 4.